Reviva Pharmaceuticals I... (RVPH)
NASDAQ: RVPH
· Real-Time Price · USD
0.84
0.06 (8.14%)
At close: May 13, 2025, 3:11 PM
8.14% (1D)
| Bid | 0.81 |
| Market Cap | 39.14M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.92M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -0.93 |
| Forward PE | -0.98 |
| Analyst | Buy |
| Ask | 0.84 |
| Volume | 614,694 |
| Avg. Volume (20D) | 902,050 |
| Open | 0.77 |
| Previous Close | 0.78 |
| Day's Range | 0.76 - 0.86 |
| 52-Week Range | 0.49 - 4.28 |
| Beta | 0.07 |
About RVPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RVPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RVPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-34.91%
Reviva Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
-39.13%
Reviva Pharmaceuticals shares are trading lower after the company announced a $18 million public offering.
5 months ago · seekingalpha.com
Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is LowReviva Pharmaceuticals aims to improve schizophrenia treatment with Brilaroxazine, showing promising Phase 3 data but needing funding for a second trial to meet FDA requirements. Reviva should announc...